Literature DB >> 8565172

Inhibition of neointimal proliferation with low-dose irradiation from a beta-particle-emitting stent.

J R Laird1, A J Carter, W M Kufs, T G Hoopes, A Farb, S H Nott, R E Fischell, D R Fischell, R Virmani, T A Fischell.   

Abstract

BACKGROUND: Restenosis after successful percutaneous transluminal coronary angioplasty is the major factor limiting the long-term effectiveness of this procedure. Neointimal proliferation in response to arterial injury is an important contributor to restenosis. The use of radiation for the treatment of malignant and benign proliferative conditions has been well established. External beam irradiation and endovascular irradiation by use of an after-loading technique have been shown to inhibit neointimal proliferation in experimental models of restenosis. The objective of this study was to investigate whether low-dose irradiation from a beta-particle-emitting stent would inhibit neointimal proliferation after placement in porcine iliac arteries. METHODS AND
RESULTS: Fourteen titanium-mesh stents were implanted in the iliac arteries of nine NIH miniature swine. There were seven beta-particle-emitting radioisotope stents (32P, activity level 0.14 microCi) and seven control stents (31P, nonradioactive). Treatment effect was assessed by angiography and histomorphological examination of the stented iliac segments 28 days after implantation. There was a significant reduction in neointimal area (1.76 +/- 0.37 mm2 versus 2.81 +/- 1.22 mm2, P = .05) and percent area stenosis (24.6 +/- 2.9% versus 36.0 +/- 10.7%, P = .02) within the beta-particle-emitting stents compared with the control stents. Neointimal thickness, which was assessed at each wire site, was also significantly less within the treatment stents (0.26 +/- 0.04 mm versus 0.38 +/- 0.10 mm, P = .012). Scanning electron microscopy was performed on sections from four stents. This demonstrated endothelialization of both the treatment and control stents. There was no excess inflammatory reaction or fibrosis in the media, adventitia, or perivascular space of vessels treated with the beta-particle-emitting stent compared with control vessels. At 28 days, there was no difference in smooth muscle cell proliferation as measured by the proliferating cell nuclear antigen index.
CONCLUSIONS: A local, continuous source of low-dose endovascular irradiation via a beta-particle-emitting stent inhibits neointimal formation in porcine arteries. This low dose of local irradiation did not prevent endothelialization of the stents. This novel technique offers promise for the prevention of restenosis and warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8565172     DOI: 10.1161/01.cir.93.3.529

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

Review 1.  The radioisotope stent for the prevention of restenosis.

Authors:  T A Fischell; C Hehrlein
Journal:  Herz       Date:  1998-09       Impact factor: 1.443

2.  Intravascular stents: a new technique for tissue processing for histology, immunohistochemistry, and transmission electron microscopy.

Authors:  N Malik; J Gunn; C M Holt; L Shepherd; S E Francis; C M Newman; D C Crossman; D C Cumberland
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

3.  Prevention of vascular restenosis with radiation.

Authors:  P S Teirstein
Journal:  Tex Heart Inst J       Date:  1998

Review 4.  [Pathophysiology and therapeutic concepts in coronary restenosis].

Authors:  H G Klues; P W Radke; R Hoffmann; J vom Dahl
Journal:  Herz       Date:  1997-12       Impact factor: 1.443

Review 5.  [Intravascular irradiation in the combined therapy and prevention of restenosis. Overview].

Authors:  D Baumgart; U Quast; R Erbel
Journal:  Herz       Date:  1997-12       Impact factor: 1.443

Review 6.  [Stent restenosis: therapy concepts and possibilities for prevention].

Authors:  P W Radke; J vom Dahl; H G Klues
Journal:  Med Klin (Munich)       Date:  1999-02-15

Review 7.  [Intracoronary brachytherapy with strontium/yttrium-90. Initial experiences in Germany].

Authors:  S Silber; P von Rottkay; A Gielow; A Schneider; A Bauer; H Schöfer
Journal:  Herz       Date:  1998-09       Impact factor: 1.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.